Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
N Engl J Med
.
2020 May 21;382(21):e65.
doi: 10.1056/NEJMc2004861.
Authors
Charles J Ferro
1
,
Pantelis Sarafidis
2
,
Alberto Ortiz
3
Affiliations
1
University Hospitals Birmingham, Birmingham, United Kingdom.
2
Aristotle University of Thessaloniki, Thessaloniki, Greece.
3
Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain aortiz@fjd.es.
PMID:
32433853
DOI:
10.1056/NEJMc2004861
No abstract available
Publication types
Letter
Comment
MeSH terms
Cardiovascular Diseases*
Cholesterol, LDL
Humans
Lipoprotein(a)*
Risk Factors
Substances
Cholesterol, LDL
Lipoprotein(a)